$3396 | SAVE $599 | Single User
$6792 | SAVE $1,198 | Site License
$10187 | SAVE $1,798 | Enterprise License

EpiCast Report: Huntington’s Disease - Epidemiology Forecast to 2024
[Published by Global Data]

Published by Global Data: 09 Dec 2015 | 17800 | In Stock

Introduction

EpiCast Report: Huntington’s Disease - Epidemiology Forecast to 2024

Summary

Huntington’s disease (HD) is a rare, inherited, genetic disorder that causes progressive degeneration of the nerve cells of the brain especially the caudate, the putamen, and the cerebral cortex. As the brain cells die, a person with HD is unable to control movements, recall events, make decisions, and control emotions, and the disorder leads to incapacitation, cognitive and psychiatric disorders, and eventually death. The signs and symptoms of HD mostly appear between the ages 30-40 years, although the onset of disease may occur earlier or later in life. Therefore the disease is mostly of adult onset. The average lifespan of a person after being diagnosed with adult-onset HD is about 15-20 years. When the onset of the disease begins earlier than the age 20 years, the condition is called juvenile HD. Juvenile HD presents somewhat different symptoms and has a faster disease progression.

GlobalData epidemiologists forecast an increase in the diagnosed prevalence of HD over the ten-year forecast period. The number of diagnosed prevalent cases of HD in the 7MM will increase from 57,314 cases in 2014 to 60,743 cases in 2024, with an AGR of 0.60% during the forecast period. For juvenile HD, GlobalData epidemiologists forecast an increase from 1,000 diagnosed prevalent cases in 2014 to 1,013 diagnosed prevalent cases in 2024, in the 7MM, with an AGR of 0.13%.

GlobalData epidemiologists used the available data on HD to the best extent possible to provide the most insightful epidemiological forecast for the diagnosed prevalent cases of HD, diagnosed prevalent cases of juvenile HD, diagnosed prevalent cases of HD by age at onset, and diagnosed prevalent cases of adults with juvenile-onset HD that progressed to adulthood in the 7MM. All sources for the 7MM assessed HD by diagnostic testing, including genetic tests. Additionally, the forecast methodology was kept consistent across the 7MM to allow for a meaningful comparison of the projected diagnosed prevalent cases of HD across the markets.

Scope

- The Huntington’s Disease EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for Huntington’s disease (HD) in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast of the diagnosed prevalent cases of HD and juvenile HD, diagnosed prevalent cases of Huntington's disease by age at onset, and diagnosed prevalent cases of adults with juvenile onset HD that progressed to adulthood, segmented by age and sex.

- The HD epidemiology report is written and developed by Masters- and PhD-level epidemiologists.

- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The Huntington’s Disease EpiCast report will allow you to -

- Develop business strategies by understanding the trends shaping and driving the global HD market.

- Quantify patient populations in the global HD market to improve product design, pricing, and launch plans.

- Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for HD therapeutics in each of the markets covered.

Table of Contents
for EpiCast Report: Huntington’s Disease - Epidemiology Forecast to 2024 [Published by Global Data]

  • 1 Table of Contents

    1 Table of Contents 4

    1.1 List of Tables 5

    1.2 List of Figures 6

    2 Introduction 7

    2.1 Catalyst 7

    2.2 Related Reports 8

    3 Epidemiology 9

    3.1 Disease Background 9

    3.2 Risk Factors and Complications 10

    3.3 Global Trends 11

    3.3.1 Diagnosed Prevalence of Huntington’s Disease - 7MM 11

    3.4 Forecast Methodology 13

    3.4.1 Sources Used 16

    3.4.2 Sources Not Used 19

    3.4.3 Forecast Assumptions and Methods 19

    3.5 Epidemiological Forecast of Huntington’s Disease (2014-2024) 22

    3.5.1 Diagnosed Prevalent Cases 22

    3.5.2 Diagnosed Prevalent Cases of Huntington's Disease by Age at Onset 35

    3.5.3 Diagnosed Prevalent Cases of Adults with Juvenile Onset Huntington's Disease that Progressed to Adulthood, Ages ≥20 Years 36

    3.6 Discussion 38

    3.6.1 Epidemiological Forecast Insight 38

    3.6.2 Limitations of the Analysis 39

    3.6.3 Strengths of the Analysis 39

    4 Appendix 41

    4.1 Bibliography 41

    4.2 About the Authors 44

    4.2.1 Epidemiologists 44

    4.2.2 Reviewers 44

    4.2.3 Global Director of Therapy Analysis and Epidemiology 45

    4.2.4 Global Head of Healthcare 46

    4.3 About GlobalData 47

    4.4 About EpiCast 47

    4.5 Disclaimer 48

List Of Tables
in EpiCast Report: Huntington’s Disease - Epidemiology Forecast to 2024 [Published by Global Data]

1.1 List of Tables

Table 1: Risk Factors and Complications for Huntington’s Disease 10

Table 2: 7MM Estimates for the Diagnosed Prevalence of Huntington’s Disease 13

Table 3: 7MM, Sources of Epidemiological Data Used for the Forecast of Huntington’s Disease Diagnosed Prevalent Cases 14

Table 4: 7MM, Sources of Epidemiological Data Used for the Forecast of Juvenile Huntington’s Disease Diagnosed Prevalent Cases 15

Table 5: 7MM, Sources of Epidemiological Data Used for the Forecast of Huntington’s Disease Diagnosed Prevalent Cases by Age at Onset 16

Table 6: 7MM, Diagnosed Prevalent Cases of Huntington’s Disease, All Ages, Both Sexes, N, 2014-2024 23

Table 7: 7MM, Diagnosed Prevalent Cases of Huntington’s Disease by Age Group, Both Sexes, N (%), 2014 25

Table 8: 7MM, Sex-Specific Diagnosed Prevalent Cases of Huntington’s Disease, All Ages, N (%), 2014 27

Table 9: 7MM, Diagnosed Prevalent Cases of Juvenile Huntington’s Disease, Age <20 Years, Both Sexes, N, 2014-2024 30

Table 10: 7MM, Age-Specific Diagnosed Prevalent Cases of Juvenile Huntington’s Disease, Both Sexes, N (%), 2014 32

Table 11: 7MM, Sex-Specific Diagnosed Prevalent Cases of Juvenile Huntington’s Disease, Age <20 Years, N (%), 2014 34

Table 12: 7MM, Diagnosed Prevalent Cases of Adults with Juvenile-Onset Huntington’s Disease that Progressed to Adulthood, Age ≥20 Years, Both Sexes, N, 2014-2024 37

List Of Figures, Charts and Diagrams
in EpiCast Report: Huntington’s Disease - Epidemiology Forecast to 2024 [Published by Global Data]

1.2 List of Figures

Figure 1: 7MM, Diagnosed Prevalent Cases of Huntington’s Disease, All Ages, Both Sexes, N, 2014-2024 23

Figure 2: 7MM, Diagnosed Prevalent Cases of Huntington’s Disease by Age Group, Both Sexes, N, 2014 26

Figure 3: 7MM, Diagnosed Prevalent Cases of Huntington's Disease, by Sex, All Ages, N, 2014 28

Figure 4: 7MM, Age-Standardized Diagnosed Prevalence of Huntington’s Disease (%) by Sex, All Ages, 2014 29

Figure 5: 7MM, Diagnosed Prevalent Cases of Juvenile Huntington’s Disease, Age <20 Years, Both Sexes, N, 2014-2024 31

Figure 6: 7MM, Diagnosed Prevalent Cases of Juvenile Huntington’s Disease by Age Group, Both Sexes, N 33

Figure 7: 7MM, Diagnosed Prevalent Cases of Juvenile Huntington's Disease by Sex, Age <20 Years, N, 2014 35

Figure 8: 7MM, Diagnosed Prevalent Cases of Huntington's Disease by Age at Onset, Both Sexes, N, 2014 36

Figure 9: 7MM, Diagnosed Prevalent Cases of Adults with Juvenile-Onset Huntington's Disease that Progressed to Adulthood, Age ≥20 Years, Both Sexes, N, 2014 37

Additional Details

Publisher

Global Data

Publisher Information

Reference

17800 | GDHCER108-15

Number of Pages

49

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! EpiCast Report: Non-Hodgkin’s Lymphoma - Epidemiology Forecast to 2024
EpiCast Report: Non-Hodgkin’s Lymphoma - Epidemiology Forecast to 2024SummaryNon-Hodgkin’s Lymphoma ...
01 Jan 2016 by Global Data USD $3,396 (normally
USD $3,995)
More Info
SAVE 15% today! EpiCast Report: Pulmonary Arterial Hypertension - Epidemiology Forecast to 2024
EpiCast Report: Pulmonary Arterial Hypertension - Epidemiology Forecast to 2024SummaryPulmonary Arte...
01 Jan 2016 by Global Data USD $3,396 (normally
USD $3,995)
More Info
SAVE 15% today! EpiCast Report: Small Cell Lung Cancer - Epidemiology Forecast to 2024
EpiCast Report: Small Cell Lung Cancer - Epidemiology Forecast to 2024SummarySmall Cell Lung Cancer ...
01 Jan 2016 by Global Data USD $3,396 (normally
USD $3,995)
More Info
SAVE 15% today! EpiCast Report: Vasculitis - Epidemiology Forecast to 2024
EpiCast Report: Vasculitis - Epidemiology Forecast to 2024SummaryVasculitis is a group of heterogene...
01 Jan 2016 by Global Data USD $3,396 (normally
USD $3,995)
More Info
SAVE 15% today! EpiCast Report: Chronic Hepatitis B - Epidemiology Forecast to 2024
EpiCast Report: Chronic Hepatitis B - Epidemiology Forecast to 2024SummaryThe Hepatitis B Virus (HBV...
24 Dec 2015 by Global Data USD $3,396 (normally
USD $3,995)
More Info
SAVE 15% today! EpiCast Report: Respiratory Syncytial Virus Infection - Epidemiology Forecast to 2024
EpiCast Report: Respiratory Syncytial Virus Infection - Epidemiology Forecast to 2024SummaryRSV is a...
23 Dec 2015 by Global Data USD $3,396 (normally
USD $3,995)
More Info
SAVE 15% today! EpiCast Report: Sjögren’s Syndrome - Epidemiology Forecast to 2024
EpiCast Report: Sjögren’s Syndrome - Epidemiology Forecast to 2024SummarySjögren’s syndrome (SS) is ...
09 Dec 2015 by Global Data USD $3,396 (normally
USD $3,995)
More Info
SAVE 15% today! EpiCast Report: Systemic Sclerosis (Scleroderma) - Epidemiology Forecast to 2024
EpiCast Report: Systemic Sclerosis (Scleroderma) - Epidemiology Forecast to 2024SummarySystemic scle...
09 Dec 2015 by Global Data USD $3,396 (normally
USD $3,995)
More Info
SAVE 15% today! EpiCast Report: Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology Forecast to 2023
EpiCast Report: Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology Forecast to 2023SummaryC...
01 Dec 2015 by Global Data USD $3,396 (normally
USD $3,995)
More Info
SAVE 15% today! EpiCast Report: Brain Cancer - Epidemiology Forecast to 2024
EpiCast Report: Brain Cancer - Epidemiology Forecast to 2024SummaryPrimary brain cancer is defined a...
01 Dec 2015 by Global Data USD $3,396 (normally
USD $3,995)
More Info

This report is published by Global Data

Download Free Report Summary PDF

EpiCast Report: Huntington’s Disease - Epidemiology Forecast to 2024 [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...